Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Olivier Antoine M. Charmeil
CEOOlivier Antoine M. Charmeil
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
112.12B
Market cap112.12B
Price-Earnings ratio
19.10
Price-Earnings ratio19.10
Dividend yield
3.48%
Dividend yield3.48%
Average volume
2.84M
Average volume2.84M
High today
$46.17
High today$46.17
Low today
$45.43
Low today$45.43
Open price
$45.67
Open price$45.67
Volume
2.83M
Volume2.83M
52 Week high
$55.73
52 Week high$55.73
52 Week low
$43.32
52 Week low$43.32

SNY News

TipRanks 14h
Sanofi Raises €2.3 Billion in Multi-Tranche Euro Bond Offering

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 1d
Giants Costco, Sanofi, and SAP Raise Dividends by Over 10%

Several stocks with market capitalizations above $100 billion just made notable dividend announcements. These names are among the largest in their respective in...

Giants Costco, Sanofi, and SAP Raise Dividends by Over 10%
TipRanks 1d
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease

Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions D...

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

More SNY News

TipRanks 1d
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch

Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions D...

TipRanks 2d
IDT Australia tips sharp earnings improvement on Sanofi tie-up and US policy tailwinds

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Nasdaq 6d
Company News for Apr 24, 2026

Honeywell International Inc. ( HON ) shares fell 2.6% after reporting first-quarter 2026 revenues of $9.14 billion, missing the Zacks Consensus Estimate by 1.28...

Company News for Apr 24, 2026
TipRanks 6d
Gujarat Themis Biosyn to Buy Sanofi Anti-Infective Brands in €158 Million Deal

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 6d
Sanofi Advances Amlitelimab Program With Key Drug-Interaction Study Completion

Sanofi (SNYNF) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions D...

Benzinga 6d
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat

Sanofi, Regeneron Win FDA Approval CSU is a skin condition characterized by itchy hives, swelling (angioedema), or both, appearing almost daily for six weeks o...

FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat
Investor's Business Daily 7d
Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO

Technology Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO Licensing Sanofi (SNY) stock popped early Thursday after the French pharma gi...

Sanofi Leans On Dupixent For First-Quarter Beat A Week Ahead Of New CEO

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.